Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
Batten disease is the most common form of a group of rare disorders known as neuronal ceroid lipofuscinoses (NCLs). Batten disease is an inherited genetic disorder that causes a build-up of lipopigments in the body’s tissues. Batten disease refers to a juvenile form of NCL, but the other forms of NCL can also be referred to as Batten disease. The forms of NCL include:
Batten disease is caused by abnormalities in genes that are involved with the production and use of certain bodily proteins. The disease results in a build up of fats and proteins called lipopigments in the cells of the brain, eyes, skin, and other tissues.
Researchers have made progress in identifying the defective enzymes and mutated genes that underlie these disorders, but it is not yet known exactly how the gene mutations cause this build up of lipopigments.
Since Batten disease is an inherited condition, people at risk include:
Batten disease may cause:
Symptoms of Batten disease are similar in each type of the disease. However, the time of appearance, severity, and rate of progression of symptoms can vary depending on the type of the disease. For example:
Infantile NCL (Santavuori-Haltia disease)—Symptoms begin to appear between 6 months-2 years of age and progress rapidly. Children with this type generally live until age 5, though some survive in a vegetative state a few years longer.
Late infantile NCL (Jansky-Bielschowsky disease)—Symptoms begin to appear between 2-4 years of age and progress rapidly. Children with this type usually live until ages 8-12.
Juvenile NCL (Spielmeyer-Vogt-Sjogren-Batten disease)—Symptoms begin to appear between 5-8 years of age and progress less rapidly. Those with this type usually live until their late teens or early 20s; and in some cases, into their 30s.
Adult NCL (Kufs disease or Party's disease)—Symptoms usually begin to appear before 40 years of age. Symptoms progress slowly and are usually milder. However, this form of the disease usually does shorten a person's life span.
You will be asked about your symptoms and medical and family history. A physical exam will be done. In most cases, the first symptoms involve vision problems. An eye exam may lead to the initial diagnosis.
Other tests may include:
Copyright © Nucleus Medical Media, Inc.
Imaging tests assess internal structures (like the brain) for abnormalities. These tests may include:
An electroencephalogram (EEG) evaluates the electrical activity of the brain.
Copyright © Nucleus Medical Media, Inc.
There is no known treatment that will stop the progression or effects of Batten disease. Treatment will depend on the types of symptoms present. The goal is to ease symptoms. Options include:
If there is a high risk of malnutrition or dehydration, a nasogastric tube can be used. It is a long, narrow tube that is placed through the nose and into the stomach. Liquid nutrition, water, and medications can be delivered through the tube.
Other supportive treatments may include:
There is no known way to prevent Batten disease. If you have Batten disease or have a family history of the disorder, you can talk to a genetic counselor when deciding to have children.
National Institute of Neurological Disorders and Stroke
NIH Office of Rare Diseases Research
About Kids Health—The Hospital for Sick Children
Batten Disease Support and Research Association
Batten disease fact sheet. National Institute of Neurological Disorders and Stroke website. Available at: https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Batten-Disease-Fact-Sheet. Updated May 10, 2017. Accessed March 16, 2018.
Home nasogastric tube feeding. University of Pittsburgh Medical Center website. Available at: http://www.upmc.com/patients-visitors/education/nutrition/Pages/home-nasogastric-tube-feeding.aspx. Accessed March 16, 2018.
How are genetic conditions diagnosed? Genetics Home Reference website. Available at: https://ghr.nlm.nih.gov/handbook/consult/diagnosis. Updated March 13, 2018. Accessed March 16, 2018.
Sondhi D, Hackett NR, Apblett RL, Kaminsky SM, Pergolizzi RG, Crystal RG. Feasibility of gene therapy for late neuronal ceroid lipofuscinosis. Arch Neurol. 2001;58(11):1793-1798.
Taupin P. HuCNS-SC (StemCells). Curr Opin Mol Ther. 2006;8(2):156-163.
What is Batten disease? Batten Disease Support and Research Association website. Available at: http://bdsra.org/what-is-batten-disease. Accessed March 16, 2018.
Last reviewed March 2018 by EBSCO Medical Review Board James P. Cornell, MD Last Updated: 3/21/2016